Clinical trial
Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
NCT02594943 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
- Lead sponsor
- Region Skane
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- August 31, 2018
- Completion date
- December 31, 2019
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.